Scarica l'app Stockscreener
46.58
0.85%
-0.40
Dopo l'orario di chiusura:
46.60
0.02
+0.04%
Precedente Chiudi:
$46.98
Aprire:
$46.65
Volume 24 ore:
732.22K
Relative Volume:
0.75
Capitalizzazione di mercato:
$1.68B
Reddito:
$117.67M
Utile/perdita netta:
$-1.88B
Rapporto P/E:
-0.7694
EPS:
-60.5369
Flusso di cassa netto:
$-621.36M
1 W Prestazione:
+21.56%
1M Prestazione:
+36.04%
6M Prestazione:
+44.97%
1 anno Prestazione:
+251.81%
Intervallo 1D:
$45.56
$48.44
Intervallo di 1 settimana:
$38.89
$49.50
Portata 52W:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
(833) 694-2553
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Confronta GRAL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
46.58 | 1.69B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
468.00 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
185.91 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
627.17 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.38 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.24 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Grail Inc Borsa (GRAL) Ultime notizie
GRAIL to present first PATHFINDER 2 results at ESMO Congress - Investing.com
GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC - MarketScreener
32,000-Patient Study: GRAIL's Blood Test Doubles Early Cancer Detection Rate in Landmark Research - Stock Titan
GRAIL (NASDAQ:GRAL) Trading 7.2% HigherShould You Buy? - MarketBeat
Will GRAIL's (GRAL) New Sunnyvale HQ Boost Its Competitive Position or Strain Resources? - simplywall.st
Grail rallies 30% in wake of Quest agreement - MSN
GRAIL Gains Momentum Post-IPO Amid Strong Sales, Partnerships, and Executive Share Activity - MSN
Big Money Moves: Is GRAIL LLC affected by consumer sentimentJuly 2025 Pullbacks & Safe Entry Zone Tips - خودرو بانک
GRAIL Inc Signs New Headquarters Lease Agreement - MSN
GRAIL, Inc. $GRAL Shares Acquired by Wesbanco Bank Inc. - MarketBeat
Biotech company ditches Menlo Park for another Bay Area headquarters - The Business Journals
Portfolio Update: Is GRAIL LLC stock a value trapWeekly Volume Report & Detailed Earnings Play Strategies - خودرو بانک
Jacobs Levy Equity Management Inc. Sells 936,524 Shares of GRAIL, Inc. $GRAL - MarketBeat
GRAIL teams up with Quest to widen access to Galleri cancer test - MSN
GRAIL (NASDAQ:GRAL) Trading Up 9.1%What's Next? - MarketBeat
GRAIL, Inc. (GRAL): A Bull Case Theory - MSN
Aug Highlights: Can GRAIL LLC ride the EV waveQuarterly Earnings Summary & Smart Money Movement Alerts - خودرو بانک
Trend Recap: Can GRAIL LLC continue delivering strong returnsGap Up & Low Risk Investment Opportunities - خودرو بانک
Aug Closing: Can GRAIL LLC expand into new marketsJuly 2025 Snapshot & Comprehensive Market Scan Reports - خودرو بانک
Merger Talk: Can GRAIL LLC grow without dilutionQuarterly Profit Summary & Free Technical Pattern Based Buy Signals - خودرو بانک
Scientech Research LLC Takes Position in GRAIL, Inc. $GRAL - MarketBeat
What institutional flow reveals about GRAIL LLCPortfolio Update Report & Long-Term Safe Investment Plans - newser.com
Grail 2024 revenue guidance range above consensus - MSN
AQR Capital Management LLC Purchases 506,440 Shares of GRAIL, Inc. $GRAL - MarketBeat
Sessa Capital IM L.P. Sells 1,081,724 Shares of GRAIL, Inc. $GRAL - MarketBeat
Raymond James Financial Inc. Has $3.10 Million Stock Holdings in GRAIL, Inc. $GRAL - MarketBeat
More Blood Tests for Cancer Hit the Market - Barron's
One Year After Illumina/Grail – How Are EU Competition Authorities Now Dealing With Below-Threshold Mergers - Crowell & Moring LLP
GRAIL to Present Early Cancer Detection Efforts at Bernstein Healthcare Forum - geneonline.com
GRAIL (GRAL) Stock Surges 19% In Last Week - simplywall.st
GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors2nd Annual Healthcare Forum - PR Newswire
GRAIL, Inc. $GRAL Shares Sold by Newtyn Management LLC - MarketBeat
Ieq Capital LLC Buys 8,435 Shares of GRAIL, Inc. $GRAL - MarketBeat
Can GRAIL LLC Escape Recent Bear ChannelTrade Entry Summary & Real-Time Volume Analysis - beatles.ru
GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference - 富途牛牛
GRAIL stock tumbles on short-seller report By Investing.com - Investing.com Nigeria
Russell Investments Group Ltd. Sells 65,244 Shares of GRAIL, Inc. $GRAL - MarketBeat
GRAIL’s Galleri Multi-Cancer Test Shows Strong Performance in PATHFINDER 2 Study, Paves Way for FDA Submission - MSN
Is GRAIL LLC affected by consumer sentiment2025 Performance Recap & Daily Entry Point Trade Alerts - خودرو بانک
Will GRAIL LLC benefit from rising consumer demand2025 Earnings Surprises & Growth Focused Entry Point Reports - خودرو بانک
New Highs: Can GRAIL LLC navigate macro headwindsJuly 2025 Snapshot & Long-Term Capital Growth Ideas - خودرو بانک
Invesco Ltd. Purchases 15,890 Shares of GRAIL, Inc. $GRAL - MarketBeat
Is GRAIL LLC a strong candidate for buy and holdJuly 2025 Chart Watch & Safe Entry Momentum Stock Tips - khodrobank.com
Nuveen LLC Invests $1.54 Million in GRAIL, Inc. $GRAL - MarketBeat
Grail Inc Azioni (GRAL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):